TeleZen MD review

TeleZen MD facilitates cash-pay telehealth care across weight management, NAD+, sermorelin, glutathione and other treatment categories. The current product pages publish physician profiles, including Ozita Cooper, Michael Wasef, Andrew Sakla and James Teet, so the old claim that no prescribers are named is no longer accurate. Those profiles are company disclosures, rather than verification that one particular physician will review every patient. The terms distinguish the platform from licensed clinicians and outside pharmacies. Submitting an intake does not guarantee a clinician relationship or a prescription, and availability needs confirmation for the selected product and patient location.

The GLP-1 page offers monthly and quarterly plans with provider review, medication, supplies, expedited shipping and educational support described as included. However, the refund policy adds a mandatory four-percent payment-processing fee to every order. The human-facing comparison figure here includes that fee: selected monthly semaglutide is $174.72, and tirzepatide $278.72. The base product price alone understates the payment. Quarterly monthly equivalents are different from installment payments because multi-month plans are paid in full. Confirm the complete checkout charge, any financing terms and the later renewal amount rather than relying on a no-hidden-fees banner.

Longevity pages distinguish introductory and ongoing offers. The selected sermorelin and NAD+ injection monthly plans rise after the first month; their comparison figures include the mandatory processing fee. NAD+ nasal spray has more than one bottle size, so the smaller bottle’s price should not be applied to every nasal product. Glutathione also has separate injectable and nasal plans. Some printed longer-plan monthly equivalents do not match a simple division of the displayed plan total, making the actual checkout amount especially important. Product availability and broad claims about cellular energy, muscle or skin appearance do not establish clinical benefit for these particular preparations.

Care begins with an online history and a clinician’s assessment. Product pages describe messaging and support services, with additional clinical requirements determined by the provider. They should not be treated as a promise that laboratory work will never be needed or that every outside test is included. The terms say prescriptions are fulfilled by outside licensed 503A pharmacies selected according to clinical, availability and operational considerations. Patients do not choose the dispensing pharmacy through this arrangement, and partners can change. Ask for the actual facility and location before dispensing, rather than treating a general FDA-regulated-pharmacy label as product approval or proof of an individual batch’s quality.

The cancellation policy is restrictive and internally uneven. Requests must be made within twelve hours of ordering, but another provision treats entry into processing, including clinician review, as final. A separate paragraph allows an eligible pre-compounding refund with deductions, so the twelve-hour window should not be presented as an unconditional right to reverse an order. A completed consultation can leave a nonrefundable visit fee, and the four-percent processing fee is not returned. Even a medically ineligible patient can have the completed consultation fee deducted. Ask which stage the order has reached and obtain the applicable refund calculation rather than assuming either every charge is refundable or no exception exists.

The separate one-hundred-eighty-day guarantee concerns eligible medication fees after continuous participation with no measurable weight loss. It requires starting and monthly weight records, a final measurement, prescribed use and a timely claim within fourteen days after completion. Any measurable weight loss defeats that particular eligibility condition, and the consultation fee remains excluded. Approved refunds can take up to thirty business days. Delivery problems also have a short reporting window: notify the service within two business days of marked delivery, including temperature concerns. Replacement is reviewed under the policy rather than guaranteed for every delay. Financial guarantees and educational programs should not be mistaken for a clinical promise.